Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GW Pharmaceuticals PLC

www.gwpharm.com

Latest From GW Pharmaceuticals PLC

Deal Watch: Vertex Selects First Candidate Under CRISPR Gene-Editing Collaboration

Vertex hopes to develop CTX001 as a treatment for sickle cell disease and beta thalassemia. Allergan adds stalled uterine fibroid candidate in buyout of troubled Repros, Juno licenses multiple myeloma candidate from Lilly.

Deals M & A

Interview: GW Pharma Gears Up For Pivotal 2018

The UK group has raised nearly $320m this week which will be used to build commercial organizations in the US and Europe ahead of potential approvals for its cannabinoid epilepsy therapy Epidiolex.

Neurology Pediatrics

Priority Review Designations In US: Third Quarter Spike Continues In 2017

Third quarter saw record total of 26 announcements for priority review designations; drop-off now likely.

Review Pathway FDA

Keeping Track: New MCL Treatment Calquence, Submissions Galore, And A Breakthrough Designation For GSK

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Review Pathway
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • GW Pharmaceuticals PLC
  • Senior Management
  • Justin Gover, CEO
    Scott Giacobello, CFO
    Chris Tovey, COO
    Volker Knappertz , MD, CMO
  • Contact Info
  • GW Pharmaceuticals PLC
    Phone: (44) 1223 266800
    Sovereign House
    Vision Park
    Histon, Cambridge, CB24 9BZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register